O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/18/2020ACC: 0001209191-20-047168
Officer· Chief Medical Officer
Since Jun 2018
+62.00
Net shares
Net buyer
$952.01
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
62.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+31.00
Price / share
$30.71
Trade value
$952.01
% of position
1.5%
8/14/2020
2.13K→2.16K
Total
Net shares
+31.00
Net value
$952.01
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2020 | A · Award | +31.00 | $30.71 | $952.01 | 1.5% | 2.13K | 2.16K |
| Total | +31.00 | $952.01 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
31.00 shares
Shares
+31.00
Strike price
36.13
Held after
31.00
Exercisable
—
8/14/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock31.00 shares | 8/14/2020 | A · Award | +31.00 | 36.13 | — | 31.00 |